PD-023

Managing Your MS Patients in the Era of COVID-19

While MS itself does not increase the risk of contracting COVID-19, treatment decisions should be individualized and made collaboratively between the patient and his or her healthcare provider during the current pandemic. It is imperative that clinicians recognize which patients will benefit from which disease-modifying therapies (DMTs), and that they address patient concerns and provide […]

Read More
By Simone Kahmeyer |
DETAIL